1846 — EuroEyes International Eye Clinic Balance Sheet
0.000.00%
- HK$1.05bn
- HK$683.70m
- HK$715.68m
- 79
- 73
- 55
- 83
Annual balance sheet for EuroEyes International Eye Clinic, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 762 | 862 | 780 | 720 | 653 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 39.8 | 35.7 | 17.8 | 25.8 | 21.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 898 | 957 | 838 | 788 | 714 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 365 | 356 | 452 | 622 | 567 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,314 | 1,369 | 1,541 | 1,754 | 1,599 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 127 | 142 | 164 | 170 | 152 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 361 | 363 | 527 | 619 | 506 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 953 | 1,006 | 1,014 | 1,135 | 1,093 |
| Total Liabilities & Shareholders' Equity | 1,314 | 1,369 | 1,541 | 1,754 | 1,599 |
| Total Common Shares Outstanding |